Persistent Low-Level “Real” Human Chorionic Gonadotropin: A Clinical Challenge and a Therapeutic Dilemma
- 31 May 2002
- journal article
- case report
- Published by Elsevier in Gynecologic Oncology
- Vol. 85 (2) , 315-320
- https://doi.org/10.1006/gyno.2002.6622
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Falsely elevated human chorionic gonadotropin leading to unnecessary therapy1Obstetrics & Gynecology, 2001
- Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic TumorsJournal of Clinical Oncology, 2000
- False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrationsThe Lancet, 2000
- Phantom hCG and Phantom ChoriocarcinomaGynecologic Oncology, 1998
- Interrelationships among Human Chorionic Gonadotropin (hCG), 17β-Estradiol, Progesterone, and Estriol in Maternal Serum: Evidence for an Inhibitory Effect of the Fetal Adrenal on Secretion of hCG*Journal of Clinical Endocrinology & Metabolism, 1983